Mandate

Vinge advises Tobii Technology

August 25, 2014

Vinge has advised Tobii Technology in connection with the Sixth Swedish National Pension Fund SEK 100 million investment in the company. Tobii Technology is the leader and pioneer in eye tracking, a technology that makes it possible for computers to know where users are looking. It is revolutionizing computer interaction and is also widely used in various fields of human research. Tobii delivers innovative and award winning solutions for markets such as consumer computers, communication aids, behavioural research and vehicles.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates David Andersson and Filip Brosset.

 

 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025